Skip to main content
Close

Neuro-Oncology

Protocols

Glioma (Adjuvant)

CNAJTZRT

Concomitant and Adjuvant Temozolomide for Newly Diagnosed Malignant Gliomas

CNELTZRT

Treatment of Elderly Newly Diagnosed Glioma Patient with Concurrent and Adjuvant Temozolomide and Radiation Therapy 

Glioma (Advanced )

CNBEV

Palliative Therapy for Recurrent Malignant Gliomas Using Bevacizumab With or Without Concurrent Etoposide or Lomustine

CNCARV

CARBOplatin and Etoposide in the Treatment of Recurrent Ependymoma

CNCCNU

Lomustine (CCNU) for Treatment of Recurrent Malignant Brain Tumors

CNETO

Palliative Treatment of Patients with Recurrent Malignant Gliomas and Ependymoma Using Low Dose Etoposide

CNMODPCV

Modified PCV Chemotherapy of Brain Tumours Using Procarbazine, Lomustine (CCNU) and vinCRIstine

CNPROC

Standard Procarbazine for Second Line Treatment of Recurrent Brain Tumour

CNTAM

Tamoxifen for Patients with Recurrent Brain Tumours Resistant to First Line chemotherapy

CNTAMCAR (deleted 01 Aug 2017)

Second and Third Line Treatment of Recurrent Gliomas with CARBOplatin and High Dose Tamoxifen

CNTEM60

Therapy for Newly Diagnosed Malignant Brain Tumours with MGMT Methylation in Elderly Patients using Temozolomide

CNTEMOZ

Therapy for Malignant Brain Tumours Using Temozolomide

CNTEMOZMD

Therapy for Malignant Brain Tumours using Metronomic Dosing of Temozolomide

CNTMZETO

Therapy for Recurrent Malignant Brain Tumours using Temozolomide and Etoposide

Primary Neuroectodermal Tumours (PNET)

CNCCV

Adjuvant lomustine, CISplatin and vinCRIstine in Adult High-Rsk Medulloblastoma or Other Primitive Neuroectodermal Tumour

CNIME (deleted 01 Aug 2017)

Ifosfamide, Mesna and Etoposide in the Treatment of Recurrent Brain Tumours

CNMODPCV

Modified PCV Chemotherapy of Brain Tumours Using Procarbazine, Lomustine (CCNU) and vinCRIstine
  • See Glioma, Advanced

Pituitary

CNB

Therapy for Pituitary Adenomas Using Bromocriptine

CNCAB

Therapy for Pituitary Adenomas Using Cabergoline

CNLAN
Treatment of Growth Hormone Secreting Pituitary Adenoma Using Lanreotide (SOMATULINE AUTOGEL®)


CNOCTLAR

Treatment of Growth Hormone Secreting Pituitary Adenoma Using Octreotide

CNQUIN

Therapy for Pituitary Adenomas Using Quinagolide

Top

Others

USATEMBEV (See Sarcoma page)

Therapy for Advanced Solitary Fibrous Tumours and Hemangiopericytoma Using Temozolomide and Bevacizumab


Terms of use

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. 

Use of these documents is at your own risk and is subject to BC Cancer Agency's terms of use available at www.bccancer.bc.ca/legal.htm .

Tab Heading
Tab Heading
SOURCE: Neuro-Oncology ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer Agency. All Rights Reserved.

    Copyright © 2017 Provincial Health Services Authority